{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:34Z","timestamp":1786119454737,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jcp.0b013e3181dac52f","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T04:28:32Z","timestamp":1273033712000},"page":"225-229","source":"Crossref","is-referenced-by-count":73,"title":["Prazosin Versus Quetiapine for Nighttime Posttraumatic Stress Disorder Symptoms in Veterans"],"prefix":"10.1097","volume":"30","author":[{"given":"Melanie G.","family":"Byers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.smrv.2007.08.008","article-title":"Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature?","volume":"12","author":"Spoormaker","year":"2008","journal-title":"Sleep Med Rev"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/appi.ajp.158.8.1227","article-title":"CSF norepinephrine concentrations in posttraumatic stress disorder.","volume":"158","author":"Geracioti","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbances in combat veterans with post-traumatic stress disorder.","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1176\/appi.ajp.159.10.1696","article-title":"REM sleep and the early development of posttraumatic stress disorder.","volume":"159","author":"Mellman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-3223(93)90302-T","article-title":"Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report.","volume":"33","author":"Hamner","year":"1993","journal-title":"Biol Psychiatry"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:ACLI.0000008173.01153.4e","article-title":"Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.","volume":"15","author":"Ahearn","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.","volume":"160","author":"Raskind","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v63n0705","article-title":"Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.","volume":"63","author":"Raskind","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.","volume":"23","author":"Hamner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.yic.0000182116.49887.ae","article-title":"Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.","volume":"21","author":"Ahearn","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia.","volume":"161","author":"Marder","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4088\/JCP.v68n0801","article-title":"Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder.","volume":"68","author":"Dunayevich","year":"2007","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:17:42Z","timestamp":1786040262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201006000-00002"}},"subtitle":["An Assessment of Long-Term Comparative Effectiveness and Safety"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181dac52f","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}